Literature DB >> 6314513

[Inflammatory arthritis and osteoarthritis in palmoplantar pustulosis. Case report and review of the literature].

G Manigand, N Faux, J Taillandier, P Fixy.   

Abstract

The case of a 46-year-old woman, who had pustulosis palmaris three years ago, and who has been experiencing inflammatory arthritis of the manubriosternal joint for two years with intermittent exacerbations, is reported. The negative bacteriologic investigations and the failure of antibiotic therapy have established that the condition is aseptic. Among patients with a history of palmo-plantar pustulosis, approximately 10% have aseptic inflammatory arthritis or osteitis, most commonly in the anterior chest wall. Other sites are the sacroiliac joints and the spine, where radiological features mimic ankylosing spondylitis, and peripheral joints. Laboratory anomalies are not specific, and HLA B27 antigen is not associated with this syndrome. The course of the arthritis, with exacerbations and remissions, is generally benign. The relationship of this syndrome to psoriatic arthritis is unclear. Non-steroidal antirheumatic drugs are the most effective agents.

Entities:  

Mesh:

Year:  1983        PMID: 6314513

Source DB:  PubMed          Journal:  Sem Hop


  4 in total

1.  Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis.

Authors:  E Edlund; U Johnsson; L Lidgren; H Pettersson; G Sturfelt; B Svensson; J Theander; H Willén
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

2.  Anterior chest wall involvement in patients with pustulosis palmoplantaris.

Authors:  A G Jurik
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

3.  Arthropathy associated with palmoplantar pustulosis.

Authors:  E Szanto; U Linse
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

4.  Monarthritis of the manubriosternal joint. A follow-up study.

Authors:  A G Jurik; H Graudal
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.